Alan Williams
Directeur des opérations chez Adela, Inc.
Postes actifs de Alan Williams
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Adela, Inc.
 Adela, Inc. Finance/Rental/LeasingFinance Adela, Inc. is a company that is developing technology to accelerate the diagnosis and improve the management of cancer through blood tests for minimal residual disease (MRD) monitoring and multi-cancer early detection (MCED). The company is based in Branford, CT. The company's genome-wide methylome enrichment platform captures extensive, biologically-relevant genomic information to maximize test performance and improve treatment decisions. Adela's approach to MRD testing is tissue agnostic, eliminating the burden of acquiring a tumor sample. The CEO of the company is Scott Bratman. | Directeur des opérations | 11/05/2023 | - |
Historique de carrière de Alan Williams
Anciens postes connus de Alan Williams
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| STANDARD BIOTOOLS INC. | Corporate Officer/Principal | 01/01/2020 | 01/03/2023 |
| THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | 01/02/2014 | 01/04/2015 |
| AFFYMETRIX, INC. | Corporate Officer/Principal | 01/03/2009 | 01/03/2010 |
Formation de Alan Williams
| University of California, Davis | Undergraduate Degree |
| University of California, Riverside | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| THERMO FISHER SCIENTIFIC | Health Technology |
| STANDARD BIOTOOLS INC. | Commercial Services |
| Entreprise privées | 2 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Adela, Inc.
Adela, Inc. Finance/Rental/LeasingFinance Adela, Inc. is a company that is developing technology to accelerate the diagnosis and improve the management of cancer through blood tests for minimal residual disease (MRD) monitoring and multi-cancer early detection (MCED). The company is based in Branford, CT. The company's genome-wide methylome enrichment platform captures extensive, biologically-relevant genomic information to maximize test performance and improve treatment decisions. Adela's approach to MRD testing is tissue agnostic, eliminating the burden of acquiring a tumor sample. The CEO of the company is Scott Bratman. | Finance |
- Bourse
- Insiders
- Alan Williams
- Expérience
